Table 2. Performance of glomerular filtration rate estimating equations in HIV-positive and HIV-negative participants.
Performance measure | HIV-positive | HIV-negative | P valuea | |
Accuracyb (95% CI) | eGFRcr | 89 (83, 93) | 96 (90, 99) | 0.048 |
eGFRcys | 79 (72, 85) | 88 (80, 94) | 0.075 | |
eGFRcr-cys | 91 (85, 94) | 97 (91, 99) | 0.055 | |
P valuec | eGFRcr vs. eGFRcys | 0.0044 | 0.046 | - |
eGFRcr vs. eGFRcr-cys | 0.51 | 0.71 | - | |
eGFRcys vs eGFRcr-cys | <0.0001 | 0.0027 | - | |
Biasd (P25, P75) | eGFRcr | −1.1 (−12.4, 10.4) | −8.8 (−18.0, 2.9) | 0.0013 |
eGFRcys | −16.3 (−27.8, −1.8) | −12.9 (−23.8, 0.8) | 0.19 | |
eGFRcr-cys | −7.2 (−19.8, 2.2) | −9.7 (−19.1, 0.7) | 0.56 | |
P valuec | eGFRcr vs. eGFRcys | <0.0001 | 0.014 | - |
eGFRcr vs. eGFRcr-cys | <0.0001 | 0.23 | - | |
eGFRcys vs eGFRcr-cys | <0.0001 | 0.0002 | - | |
Precisione (95% CI) | eGFRcr | 22.8 (18.4, 27.3) | 20.9 (15.1, 26.7) | 0.50 |
eGFRcys | 25.9 (22.1, 29.7) | 24.5 (18.9, 30.2) | 0.61 | |
eGFRcr-cys | 22.0 (18.1, 25.9) | 19.8 (13.2, 26.4) | 0.49 | |
P valuec | eGFRcr vs. eGFRcys | 0.43 | 0.65 | - |
eGFRcr vs. eGFRcr-cys | 0.43 | 0.27 | - | |
eGFRcys vs eGFRcr-cys | 0.12 | 0.10 | - |
CI, confidence interval; eGFRcr, eGFRcys, and eGFRcr-cys are glomerular filtration rates estimated by CKD-EPI equations using plasma creatinine, cystatin C, and both biomarkers, respectively; P25 and P75, 25th and 75th percentiles, respectively.
Comparisons of a single equation between the HIV-positive and HIV-negative groups. P values in bold font indicate difference is statistically significant accounting for multiple comparisons (see text).
Accuracy defined as percentage of estimated GFR values within 30% of measured GFR.
Comparisons of a different equations within the HIV-positive or HIV-negative group. P values in bold font indicate difference is statistically significant accounting for multiple comparisons (see text).
Bias defined as difference between estimated GFR and measured GFR (mL/min/1.73 m2).
Precision defined as interquartile range of bias.